Neil Stahl, SVP Research and Development S at REGENERON PHARMACEUTICALS INC (REGN), sold 54,548 shares at $316.55 ($17.6M) on 2014-02-13, disclosed to the SEC on 2014-02-13.
Open-market sale of $17.6M REGN by SVP Research and Development S. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $324.44 | 339 | $110K | 0.6% |
| 2 | $324.44 | 414 | $134K | 0.8% |
| 3 | $324.44 | 2,619 | $850K | 4.8% |
| 4 | $324.44 | 3,465 | $1.1M | 6.4% |
| 5 | $324.44 | 4,234 | $1.4M | 7.8% |
| 6 | $324.44 | 20,865 |
| $6.8M |
| 38.5% |
| 7 | $316.55 | 1,800 | $570K | 3.2% |
| 8 | $317.58 | 5,360 | $1.7M | 9.7% |
| 9 | $318.51 | 6,418 | $2.0M | 11.6% |
| 10 | $319.47 | 3,819 | $1.2M | 6.9% |
| 11 | $320.60 | 3,575 | $1.1M | 6.5% |
| 12 | $321.17 | 1,640 | $527K | 3.0% |
| Total | $322.11 avg | 54,548 | $17.6M | 100% |
| Filing → |
| REGN | SELL | 2023-08-23 | $19.6M | — | Filing → |
| REGN | SELL | 2022-08-08 | $28.4M | — | Filing → |
| REGN | SELL | 2021-05-18 | $18.2M | — | Filing → |